Algert Global LLC Otonomy, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.72 - $2.47 $33,970 - $48,782	-19,750 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.31 $10,832 - $14,807	6,410 Added 48.05%	19,750 $41,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.2 $16,274 - $29,348	13,340 New	13,340 $26,000
Q2 2021 Aug 13, 2021	SELL	$2.06 - $2.67 $175,633 - $227,641	-85,259 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.49 - $6.23 $212,294 - $531,163	85,259 New	85,259 $217,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.